Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma
- PDF / 1,340,157 Bytes
- 7 Pages / 595.276 x 793.701 pts Page_size
- 82 Downloads / 219 Views
RESEARCH
Open Access
Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma Nan Ge1,2†, Huan-Xin Lin1,2†, Xiang-Sheng Xiao1,3†, Ling Guo1,4, Hui-Min Xu1,2, Xin Wang1,2, Ting Jin1,2, Xiu-Yu Cai1,2, Yi Liang1, Wei-Han Hu1,2*, Tiebang Kang1*
Abstract Background: Oct4 and Sox2 are two major transcription factors related to the stem cell self-renewal and differentiation. The aim of this study was to examine the association between Oct4 and Sox2 expression levels with both the clinicopathological characteristics and prognoses of patients with hypopharyngeal squamous cell carcinoma. Method: Tumor tissue samples from 85 patients with hypopharyngeal squamous cell carcinoma were collected, and the clinical follow-up data of these patients were recorded, and expression status of Oct4 and Sox2 were examined in these tissue samples by immunohistochemistry (IHC). Results: Oct4 expression was found to be an independent predictive factor for overall survival (p = 0.004) in patients with hypopharyngeal squamous cell carcinoma and was independently related to loco-regional control (p = 0.001). Although Sox2 expression status showed no significant association with overall survival (p = 0.166), disease-free survival (p = 0.680) or loco-regional control (p = 0.383), when using a subgroup analysis, the subgroup with both high Oct4 and Sox2 expression had the best prognosis (p = 0.000). Sox2 expression could be a potential prognostic predictor for patients with hypopharyngeal squamous cell carcinoma. Simultaneous analyses of Oct4 and Sox2 expression could be more effective in evaluating the prognoses of patients with hypopharyngeal squamous cell carcinoma. Conclusion: Oct4 expression is an independent predictive factor for patients with hypopharyngeal squamous cell carcinoma, suggesting that Oct4 expression may be a useful indicator for predicting the prognosis of hypopharyngeal squamous cell carcinoma.
Background Head and neck squamous cell carcinoma, including hypopharyngeal squamous cell carcinoma, is one of the most common cancers worldwide and is associated with low survival and high morbidity [1,2]. Characterized by an aggressive growth pattern and lack of obvious early symptoms, hypopharyngeal squamous cell carcinoma is a cancer with the lowest survival rates among the head and neck subsites [3,4]. Although the standard therapy of surgery plus postoperative radiation results in a * Correspondence: [email protected]; [email protected] † Contributed equally 1 State Key Laboratory of Oncology in South China, Cancer Center of Sun Yat-Sen University, Guangzhou 510060, China Full list of author information is available at the end of the article
5-year survival rate of 40-50%, most patients have nonresectable tumors when they are diagnosed [5]. Interestingly, the high mortality rate of patients is mainly due to poor loco-regional control, including local tissue invasion by the primary tumor and regional lymph node involvement rather than distant metastasis [6]. The cancer stem cell (CSC) h
Data Loading...
